247 related articles for article (PubMed ID: 26566536)
1. Epidemiology and Outcome of Trichosporon Fungemia: A Review of 185 Reported Cases From 1975 to 2014.
Liao Y; Lu X; Yang S; Luo Y; Chen Q; Yang R
Open Forum Infect Dis; 2015 Dec; 2(4):ofv141. PubMed ID: 26566536
[TBL] [Abstract][Full Text] [Related]
2. Fatal Disseminated Infection by Trichosporon asahii Under Voriconazole Therapy in a Patient with Acute Myeloid Leukemia: A Review of Breakthrough Infections by Trichosporon spp.
Ramírez I; Moncada D
Mycopathologia; 2020 Apr; 185(2):377-388. PubMed ID: 31853871
[TBL] [Abstract][Full Text] [Related]
3. Successful treatment of Trichosporon fungemia in a patient with refractory acute myeloid leukemia using voriconazole combined with liposomal amphotericin B.
Hosokawa K; Yamazaki H; Mochizuki K; Ohata K; Ishiyama K; Hayashi T; Kondo Y; Sugimori N; Okumura H; Takami A; Nakao S
Transpl Infect Dis; 2012 Apr; 14(2):184-7. PubMed ID: 22093149
[TBL] [Abstract][Full Text] [Related]
4. Hematogenous trichosporonosis in cancer patients: report of 12 cases including 5 during prophylaxis with itraconazol.
Krcmery V; Mateicka F; Kunová A; Spánik S; Gyarfás J; Sycová Z; Trupl J
Support Care Cancer; 1999 Jan; 7(1):39-43. PubMed ID: 9926973
[TBL] [Abstract][Full Text] [Related]
5. Fungemia due to Trichosporon asahii in a neutropenic child refractory to amphotericin B: clearance with voriconazole.
Antachopoulos C; Papakonstantinou E; Dotis J; Bibashi E; Tamiolaki M; Koliouskas D; Roilides E
J Pediatr Hematol Oncol; 2005 May; 27(5):283-5. PubMed ID: 15891566
[TBL] [Abstract][Full Text] [Related]
6. Bloodstream infection due to Trichosporon beigelii in a burn patient: case report and review of therapy.
Hajjeh RA; Blumberg HM
Clin Infect Dis; 1995 Apr; 20(4):913-6. PubMed ID: 7795094
[TBL] [Abstract][Full Text] [Related]
7. Factors Associated with Breakthrough Fungemia Caused by
Kimura M; Asano-Mori Y; Sakoh T; Abe M; Ueno K; Hoshino Y; Nakamura S; Umeyama T; Yamagoe S; Miyazaki Y; Baba M; Okada C; Ogura S; Mitsuki T; Yamaguchi K; Yuasa M; Kaji D; Kageyama K; Nishida A; Taya Y; Ishiwata K; Takagi S; Yamamoto H; Yamamoto G; Uchida N; Wake A; Taniguchi S; Araoka H
Antimicrob Agents Chemother; 2022 Mar; 66(3):e0208121. PubMed ID: 35041512
[TBL] [Abstract][Full Text] [Related]
8. Micafungin Breakthrough Fungemia in Patients with Hematological Disorders.
Kimura M; Araoka H; Yamamoto H; Nakamura S; Nagi M; Yamagoe S; Miyazaki Y; Ogura S; Mitsuki T; Yuasa M; Kaji D; Kageyama K; Nishida A; Taya Y; Shimazu H; Ishiwata K; Takagi S; Yamamoto G; Asano-Mori Y; Uchida N; Wake A; Taniguchi S; Yoneyama A
Antimicrob Agents Chemother; 2018 May; 62(5):. PubMed ID: 29530846
[TBL] [Abstract][Full Text] [Related]
9. Trichosporon beigelii, a new neonatal pathogen.
Yoss BS; Sautter RL; Brenker HJ
Am J Perinatol; 1997 Feb; 14(2):113-7. PubMed ID: 9259910
[TBL] [Abstract][Full Text] [Related]
10. Successful treatment of a Trichosporon beigelii septicemia in a granulocytopenic patient with amphotericin B and granulocyte colony-stimulating factor.
Grauer ME; Bokemeyer C; Bautsch W; Freund M; Link H
Infection; 1994; 22(4):283-6. PubMed ID: 7528173
[TBL] [Abstract][Full Text] [Related]
11. Breakthrough Trichosporon asahii fungemia in neutropenic patient with acute leukemia while receiving caspofungin.
Bayramoglu G; Sonmez M; Tosun I; Aydin K; Aydin F
Infection; 2008 Feb; 36(1):68-70. PubMed ID: 17882360
[TBL] [Abstract][Full Text] [Related]
12. Bloodstream infections due to Trichosporon species in paediatric patients: Results from the first national study from Turkey.
Akaslan Kara A; Çay Ü; Yalçınkaya R; Erdeniz EH; Tural Kara T; Özdemir H; Güner Özenen G; Polat M; Gayretli Aydın ZG; Alkan G; Kepenekli E; Gündeşlioğlu ÖÖ; Kıymet E; Birinci A; Kibar F; Böncüoğlu E; Şahbudak Bal Z; Alabaz D; Çiftçi E; Tanır G; Bayram N; Cengiz AB; Devrim İ
J Mycol Med; 2022 Mar; 32(1):101229. PubMed ID: 34911023
[TBL] [Abstract][Full Text] [Related]
13. Trichosporon beigelii fungemia in patients with acute leukemia: report of three cases.
Hung CC; Chang SC; Chen YC; Tien HF; Hsieh WC
J Formos Med Assoc; 1995 Mar; 94(3):127-31. PubMed ID: 7613244
[TBL] [Abstract][Full Text] [Related]
14. Pseudozyma and other non-Candida opportunistic yeast bloodstream infections in a large stem cell transplant center.
Pande A; Non LR; Romee R; Santos CA
Transpl Infect Dis; 2017 Apr; 19(2):. PubMed ID: 28099778
[TBL] [Abstract][Full Text] [Related]
15. Trichosporon beigelii: a potential cause of sepsis in premature infants.
Giacoia GP
South Med J; 1992 Dec; 85(12):1247-8. PubMed ID: 1470973
[TBL] [Abstract][Full Text] [Related]
16. Amphotericin B treatment of fungemia due to unusual pathogens in neutropenic patients: report of two cases.
Fanci R; Pecile P; Martinez RL; Fabbri A; Nicoletti P
J Chemother; 1997 Dec; 9(6):427-30. PubMed ID: 9491843
[TBL] [Abstract][Full Text] [Related]
17. Trichosporon beigelii infection: experience in a regional burn center.
Cawley MJ; Braxton GR; Haith LR; Reilly KJ; Guilday RE; Patton ML
Burns; 2000 Aug; 26(5):483-6. PubMed ID: 10812273
[TBL] [Abstract][Full Text] [Related]
18. EPICO 3.0. Empirical antifungal therapy in critically-ill hematology patients.
Llinares P; Ruiz I; Zaragoza R; Ferrer R; Rodríguez AH; Maseda E; Grau S;
Rev Iberoam Micol; 2016; 33(4):206-215. PubMed ID: 27751781
[TBL] [Abstract][Full Text] [Related]
19. Rhodotorula species fungemia: a threat to the immunocompromised host.
Anatoliotaki M; Mantadakis E; Galanakis E; Samonis G
Clin Lab; 2003; 49(1-2):49-55. PubMed ID: 12593475
[TBL] [Abstract][Full Text] [Related]
20. Use of voriconazole to successfully treat disseminated Trichosporon asahii infection in a patient with acute myeloid leukaemia.
Fournier S; Pavageau W; Feuillhade M; Deplus S; Zagdanski AM; Verola O; Dombret H; Molina JM
Eur J Clin Microbiol Infect Dis; 2002 Dec; 21(12):892-6. PubMed ID: 12525928
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
